Deutsche Bank’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.9M | Buy |
235,481
+65,461
| +39% | +$2.68M | ﹤0.01% | 980 |
|
|
2026
Q1 | $5.65M | Buy |
170,020
+14,094
| +9% | +$420K | ﹤0.01% | 1249 |
|
|
2025
Q4 | $4.65M | Buy |
155,926
+5,199
| +3% | +$170K | ﹤0.01% | 1332 |
|
|
2025
Q3 | $5.45M | Buy |
150,727
+13,803
| +10% | +$455K | ﹤0.01% | 1275 |
|
|
2025
Q2 | $4.93M | Sell |
136,924
-11,781
| -8% | -$439K | ﹤0.01% | 1248 |
|
|
2025
Q1 | $5.86M | Buy |
148,705
+1,685
| +1% | +$56.7K | ﹤0.01% | 1191 |
|
|
2024
Q4 | $4.43M | Buy |
147,020
+42,272
| +40% | +$1.21M | ﹤0.01% | 1388 |
|
|
2024
Q3 | $2.45M | Buy |
104,748
+17,362
| +20% | +$379K | ﹤0.01% | 1633 |
|
|
2024
Q2 | $1.55M | Sell |
87,386
-7,798
| -8% | -$124K | ﹤0.01% | 1759 |
|
|
2024
Q1 | $1.45M | Buy |
95,184
+3,027
| +3% | +$48.2K | ﹤0.01% | 1827 |
|
|
2023
Q4 | $1.57M | Sell |
92,157
-1,380
| -1% | -$16K | ﹤0.01% | 1805 |
|
|
2023
Q3 | $782K | Sell |
93,537
-2,411
| -3% | -$33.6K | ﹤0.01% | 1884 |
|
|
2023
Q2 | $2.38M | Sell |
95,948
-29,416
| -23% | -$760K | ﹤0.01% | 1545 |
|
|
2023
Q1 | $1.89M | Buy |
125,364
+25,148
| +25% | +$382K | ﹤0.01% | 1724 |
|
|
2022
Q4 | $1.19M | Buy |
100,216
+6,588
| +7% | +$47.8K | ﹤0.01% | 1942 |
|
|
2022
Q3 | $554K | Sell |
93,628
-2,784
| -3% | -$18.3K | ﹤0.01% | 2315 |
|
|
2022
Q2 | $409K | Buy |
96,412
+15,455
| +19% | +$96.5K | ﹤0.01% | 2734 |
|
|
2022
Q1 | $770K | Sell |
80,957
-86,134
| -52% | -$997K | ﹤0.01% | 2504 |
|
|
2021
Q4 | $3.17M | Sell |
167,091
-2,571
| -2% | -$66.7K | ﹤0.01% | 1703 |
|
|
2021
Q3 | $5.65M | Buy |
169,662
+4,434
| +3% | +$137K | ﹤0.01% | 1435 |
|
|
2021
Q2 | $6.41M | Buy |
165,228
+1,262
| +0.8% | +$49.6K | ﹤0.01% | 1387 |
|
|
2021
Q1 | $7.9M | Buy |
163,966
+48,896
| +42% | +$2.35M | ﹤0.01% | 1311 |
|
|
2020
Q4 | $5.99M | Buy |
115,070
+36,000
| +46% | +$1.22M | ﹤0.01% | 1273 |
|
|
2020
Q3 | $2.12M | Buy |
79,070
+13,229
| +20% | +$304K | ﹤0.01% | 1705 |
|
|
2020
Q2 | $1.28M | Sell |
65,841
-27,461
| -29% | -$442K | ﹤0.01% | 2068 |
|
|
2020
Q1 | $919K | Sell |
93,302
-5,813
| -6% | -$73.4K | ﹤0.01% | 2134 |
|
|
2019
Q4 | $1.1M | Sell |
99,115
-23,487
| -19% | -$179K | ﹤0.01% | 2315 |
|
|
2019
Q3 | $687K | Sell |
122,602
-959
| -0.8% | -$6.69K | ﹤0.01% | 2518 |
|
|
2019
Q2 | $1.07M | Buy |
123,561
+58,121
| +89% | +$439K | ﹤0.01% | 2802 |
|
|
2019
Q1 | $525K | Sell |
65,440
-758,724
| -92% | -$4.1M | ﹤0.01% | 3418 |
|
|
2018
Q4 | $3.38M | Buy |
824,164
+145,454
| +21% | +$723K | ﹤0.01% | 2057 |
|
|
2018
Q3 | $3.8M | Buy |
678,710
+561,176
| +477% | +$6.41M | ﹤0.01% | 2416 |
|
|
2018
Q2 | $1.55M | Sell |
117,534
-68,264
| -37% | -$939K | ﹤0.01% | 3132 |
|
|
2018
Q1 | $2.64M | Buy |
185,798
+67,808
| +57% | +$867K | ﹤0.01% | 2686 |
|
|
2017
Q4 | $965K | Buy |
117,990
+53,684
| +83% | +$469K | ﹤0.01% | 3213 |
|
|
2017
Q3 | $761K | Sell |
64,306
-20,400
| -24% | -$232K | ﹤0.01% | 3182 |
|
|
2017
Q2 | $850K | Buy |
84,706
+71,912
| +562% | +$805K | ﹤0.01% | 3143 |
|
|
2017
Q1 | $148K | Sell |
12,794
-14,958
| -54% | -$107K | ﹤0.01% | 3743 |
|
|
2016
Q4 | $128K | Buy |
27,752
+2,072
| +8% | +$12.2K | ﹤0.01% | 3951 |
|
|
2016
Q3 | $197K | Sell |
25,680
-40,096
| -61% | -$258K | ﹤0.01% | 3658 |
|
|
2016
Q2 | $397K | Buy |
65,776
+11,688
| +22% | +$95K | ﹤0.01% | 3414 |
|
|
2016
Q1 | $460K | Sell |
54,088
-3,102
| -5% | -$27.1K | ﹤0.01% | 3264 |
|
|
2015
Q4 | $682K | Sell |
57,190
-94,654
| -62% | -$1.2M | ﹤0.01% | 3116 |
|
|
2015
Q3 | $1.53M | Buy |
151,844
+68,401
| +82% | +$1.02M | ﹤0.01% | 2657 |
|
|
2015
Q2 | $1.38M | Sell |
83,443
-41,074
| -33% | -$650K | ﹤0.01% | 2749 |
|
|
2015
Q1 | $1.93M | Buy |
124,517
+51,528
| +71% | +$780K | ﹤0.01% | 2469 |
|
|
2014
Q4 | $1.16M | Buy |
72,989
+18,320
| +34% | +$239K | ﹤0.01% | 3110 |
|
|
2014
Q3 | $582K | Buy |
54,669
+109
| +0.2% | +$1.01K | ﹤0.01% | 3387 |
|
|
2014
Q2 | $511K | Buy |
54,560
+25,120
| +85% | +$161K | ﹤0.01% | 3451 |
|
|
2014
Q1 | $202K | Sell |
29,440
-23,570
| -44% | -$140K | ﹤0.01% | 3887 |
|
|
2013
Q4 | $206K | Buy |
53,010
+34,487
| +186% | +$139K | ﹤0.01% | 3683 |
|
|
2013
Q3 | $92K | Buy |
18,523
+10,902
| +143% | +$66.7K | ﹤0.01% | 4457 |
|
|
2013
Q2 | $48K | Buy |
+7,621
| New | +$48.8K | ﹤0.01% | 4530 |
|
Other funds holding TGTX
SCM
CAM
Deutsche Bank's TGTX Position: Q2 2026 in Review
Deutsche Bank increased its TG Therapeutics (TGTX) stake by 39% in Q2 2026, buying an estimated $2.68M and bringing the position to 235,481 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #980.
Deutsche Bank first reported a position in TGTX in Q2 2013 and has held it in 53 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Deutsche Bank held 235,481 shares of TG Therapeutics worth $12.9M as of Q2 2026.
- Deutsche Bank bought 65,461 TG Therapeutics shares in Q2 2026, an estimated $2.68M.
- TG Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #980 holding.
- Deutsche Bank first reported a position in TG Therapeutics in Q2 2013 and has held it in 53 quarters since.
- 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.